ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

ElevateBio founds HighPassBio to develop Fred Hutch cell therapy

Source: 
Fierce Biotech
snippet: 
ElevateBio has founded HighPassBio to advance T-cell immunotherapies based on research from the Fred Hutchinson Cancer Research Center. HighPassBio starts life with a phase 1 leukemia cell therapy.